ML22034A624: Difference between revisions
StriderTol (talk | contribs) (StriderTol Bot insert) |
StriderTol (talk | contribs) (StriderTol Bot change) |
||
| Line 19: | Line 19: | ||
=Text= | =Text= | ||
{{#Wiki_filter:Chapter 10 - Experimental Facilities | {{#Wiki_filter:Chapter 10 - Experimental Facilities Table of Contents | ||
CHAPTER 10 | |||
EXPERIMENTAL FACILITIES | |||
TABLE OF CONTENTS | |||
Section Tit le Page | |||
10.1 | |||
==SUMMARY== | ==SUMMARY== | ||
DESCRIPTION ............................................................................... 10.1-1 | DESCRIPTION............................................................................... 10.1-1 | ||
==10.2 | ==10.2 REFERENCES== | ||
................................................................................................... 10.2-1 | |||
Chapter 10 - Experimental Facilities | SHINE Medical Technologies 10-i Rev. 0 Chapter 10 - Experimental Facilities List of Tables | ||
LIST OF TABLES | |||
Number Tit le None | |||
Chapter 10 - Experimental Facilities | SHINE Medical Technologies 10-ii Rev. 0 Chapter 10 - Experimental Facilities List of Figures | ||
LIST OF FIGURES | |||
Number Tit le None | |||
SHINE Medical Technologies 10-iii Rev. 0 Chapter 10 - Experimental Facilities Acronyms and Abbreviations | |||
ACRONYMS AND ABBREVIATIONS | |||
Acronym/Abbreviation Definition None | |||
SHINE Medical Technologies 10-iv Rev. 0 Chapter 10 - Experimental Facilities Summary Description | |||
CHAPTER 10 - EXPERIMENTAL FACILITIES | |||
10.1 | |||
==SUMMARY== | ==SUMMARY== | ||
DESCRIPTION The SHINE facility does not contain experimental facilities as described in NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: | DESCRIPTION | ||
The SHINE facility does not contain experimental facilities as described in NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: | |||
Format and Content (USNRC, 1996) and the Interim Staff Guidance Augmenting NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors (USNRC, 2012). | Format and Content (USNRC, 1996) and the Interim Staff Guidance Augmenting NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors (USNRC, 2012). | ||
Chapter 10 - Experimental Facilities | SHINE Medical Technologies 10.1-1 Rev. 0 Chapter 10 - Experimental Facilities References | ||
==10.2 | ==10.2 REFERENCES== | ||
USNRC, 1996. Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, NUREG-1537, Part 1, U.S. Nuclear Regulatory Commission, February 1996. | |||
USNRC, 2012. Interim Staff Guidance Augmenting NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors, Interim Staff Guidance Augmenting NUREG-1537, Part 1, U.S. Nuclear Regulatory Commission, October 17, 2012. | USNRC, 2012. Interim Staff Guidance Augmenting NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors, Interim Staff Guidance Augmenting NUREG-1537, Part 1, U.S. Nuclear Regulatory Commission, October 17, 2012. | ||
SHINE Medical Technologies | |||
SHINE Medical Technologies 10.2-1 Rev. 0}} | |||
Revision as of 18:47, 18 November 2024
| ML22034A624 | |
| Person / Time | |
|---|---|
| Site: | SHINE Medical Technologies |
| Issue date: | 01/26/2022 |
| From: | SHINE Technologies, SHINE Health. Illuminated |
| To: | Office of Nuclear Reactor Regulation |
| Shared Package | |
| ML22034A612 | List: |
| References | |
| 2022-SMT-0007 | |
| Download: ML22034A624 (6) | |
Text
Chapter 10 - Experimental Facilities Table of Contents
CHAPTER 10
EXPERIMENTAL FACILITIES
TABLE OF CONTENTS
Section Tit le Page
10.1
SUMMARY
DESCRIPTION............................................................................... 10.1-1
10.2 REFERENCES
................................................................................................... 10.2-1
SHINE Medical Technologies 10-i Rev. 0 Chapter 10 - Experimental Facilities List of Tables
LIST OF TABLES
Number Tit le None
SHINE Medical Technologies 10-ii Rev. 0 Chapter 10 - Experimental Facilities List of Figures
LIST OF FIGURES
Number Tit le None
SHINE Medical Technologies 10-iii Rev. 0 Chapter 10 - Experimental Facilities Acronyms and Abbreviations
ACRONYMS AND ABBREVIATIONS
Acronym/Abbreviation Definition None
SHINE Medical Technologies 10-iv Rev. 0 Chapter 10 - Experimental Facilities Summary Description
CHAPTER 10 - EXPERIMENTAL FACILITIES
10.1
SUMMARY
DESCRIPTION
The SHINE facility does not contain experimental facilities as described in NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors:
Format and Content (USNRC, 1996) and the Interim Staff Guidance Augmenting NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors (USNRC, 2012).
SHINE Medical Technologies 10.1-1 Rev. 0 Chapter 10 - Experimental Facilities References
10.2 REFERENCES
USNRC, 1996. Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, NUREG-1537, Part 1, U.S. Nuclear Regulatory Commission, February 1996.
USNRC, 2012. Interim Staff Guidance Augmenting NUREG-1537, Part 1, Guidelines for Preparing and Reviewing Applications for the Licensing of Non-Power Reactors: Format and Content, for Licensing Radioisotope Production Facilities and Aqueous Homogeneous Reactors, Interim Staff Guidance Augmenting NUREG-1537, Part 1, U.S. Nuclear Regulatory Commission, October 17, 2012.
SHINE Medical Technologies 10.2-1 Rev. 0